{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000052","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.424521+00:00","generated_at":"2026-06-01T13:13:29.088388+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"GRI Bio enters into ATM equity offering agreement with H.C. Wainwright for up to $961,579","bullets":["Company may sell up to $961,579 of common stock through H.C. Wainwright as sales agent.","Wainwright receives 3% commission on gross proceeds; no obligation for Company to sell.","Shares offered on Nasdaq as at-the-market sales under May 20, 2024 prospectus supplement.","Company can suspend or terminate the agreement at any time; $10M aggregate cap also applies."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000052","json":"https://secwatch.observer/filing/0001824293-24-000052.json","markdown":"https://secwatch.observer/filing/0001824293-24-000052.md","text":"https://secwatch.observer/filing/0001824293-24-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/0001824293-24-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/val-20240520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T13:13:29.088388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}